Non-Alcoholic Steatohepatitis (NASH) is a severe progression of non-alcoholic fatty liver disease (NAFLD). It is characterized not only by fat buildup in the liver but also by inflammation and cellular damage.

What are the symptoms and risks of NASH?

NASH may be silent in its early stages but can progress to serious complications, including liver fibrosis and scarring, cirrhosis, and liver failure or liver cancer. It is also a rapidly rising cause of liver transplants worldwide.

How is fructose linked to NASH?

Fructose metabolism plays a key role in the development of NASH. It promotes fat accumulation through de novo lipogenesis, elevates uric acid levels and oxidative stress, and disrupts mitochondrial energy function, triggering liver inflammation.

What is NASH?
Symptoms and Risks
Fructose and NASH
Internal Production Risk

NASH (Non-Alcoholic Steatohepatitis)

Q: Can NASH progress even without dietary sugar?

Yes. Even in the absence of dietary sugar, endogenous fructose produced from carbohydrates, alcohol, or salt can continue to fuel the NASH process. This risk is especially high in metabolically compromised individuals. At LIV3, NASH is viewed as a downstream effect of a broken energy pathway, and targeting fructokinase is considered a proactive step to prevent or reverse damage at its metabolic root.

An advanced form of fatty liver involving inflammation and liver damage—often driven by excess fructose metabolism.

Liver Health Starts with Energy Balance

NASH isn’t just about fat in the liver—it’s about the inflammation and mitochondrial dysfunction that follow.

Fructose metabolism plays a central role in NASH by rapidly generating fat, uric acid, and oxidative stress in liver cells. Over time, this leads to inflammation, scarring, and liver damage—even in the absence of alcohol. And because the polyol pathway can produce fructose endogenously, this damage can occur even on a sugar-free diet .

SugarShield is formulated to help support liver resilience by modulating the effects of excess fructose metabolism. It’s a science-driven approach to protecting cellular energy and metabolic health—before inflammation takes hold.

Explore SugarShield

What is NASH?

Non-Alcoholic Steatohepatitis (NASH) is a severe progression of non-alcoholic fatty liver disease (NAFLD), characterized not just by fat buildup but also by liver inflammation and cellular damage.

NASH progression from fatty liver to inflammatory disease is tracked through oxidative stress biomarkers for monitoring NASH progression — clinical markers revealing when liver damage is escalating.

Symptoms and Risks

NASH may be silent in early stages but can lead to:
- Liver fibrosis and scarring
- Cirrhosis
- Liver failure or cancer

It's a rising cause of liver transplants worldwide.

Fructose and NASH

Fructose metabolism plays a key role in NASH:
- Promotes fat accumulation via de novo lipogenesis
- Elevates uric acid and oxidative stress
- Disrupts mitochondrial energy, triggering inflammation

Internal Production Risk

Even without sugar, endogenous fructose from carbs, alcohol, or salt can continue to fuel the NASH process—especially in metabolically compromised individuals.

At LIV3, we see NASH as a downstream effect of a broken energy pathway—and targeting fructokinase is a proactive step to prevent or reverse this damage at its metabolic root."

0

NASH (Non-Alcoholic Steatohepatitis)

An advanced form of fatty liver involving inflammation and liver damage—often driven by excess fructose metabolism.